147 related articles for article (PubMed ID: 10782865)
1. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.
Nagarkatti N
Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865
[TBL] [Abstract][Full Text] [Related]
2. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
[TBL] [Abstract][Full Text] [Related]
3. Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas(+) organs.
Zeytun A; Nagarkatti M; Nagarkatti PS
Blood; 2000 Mar; 95(6):2111-7. PubMed ID: 10706882
[TBL] [Abstract][Full Text] [Related]
4. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
Kamath AB; Camacho I; Nagarkatti PS; Nagarkatti M
Toxicol Appl Pharmacol; 1999 Oct; 160(2):141-55. PubMed ID: 10527913
[TBL] [Abstract][Full Text] [Related]
5. Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.
Zeytun A; Hassuneh M; Nagarkatti M; Nagarkatti PS
Blood; 1997 Sep; 90(5):1952-9. PubMed ID: 9292529
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
7. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
[TBL] [Abstract][Full Text] [Related]
8. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury.
Du C; Guan Q; Yin Z; Masterson M; Zhong R; Jevnikar AM
Transplant Proc; 2003 Nov; 35(7):2481-2. PubMed ID: 14611992
[TBL] [Abstract][Full Text] [Related]
9. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
10. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
11. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
12. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells.
Rich RF; Green WR
J Virol; 1999 May; 73(5):3826-34. PubMed ID: 10196277
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
Kehren J; Desvignes C; Krasteva M; Ducluzeau MT; Assossou O; Horand F; Hahne M; Kägi D; Kaiserlian D; Nicolas JF
J Exp Med; 1999 Mar; 189(5):779-86. PubMed ID: 10049941
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Watanabe D; Suda T; Hashimoto H; Nagata S
EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
19. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
Mittelstadt PR; Ashwell JD
J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
[TBL] [Abstract][Full Text] [Related]
20. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]